AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75N93020C00023ABTERRA BIOSCIENCES, INC.
Overview
Award facts
- Net obligations
- $540.61K
- $540,608of $540.61K potential value
- Outlays (paid to date)
- $222.61K
- $222.61K paid of $540.61K obligated$222,608
- Period of performance
- Jul 1, 2020 to Dec 31, 2022
- Ended
- Modifications
- 8
- Latest action May 23, 2022
- Contract type
- Definitive contract
- PIID 75N93020C00023
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
COMPREHENSIVE REAGENTS FOR IMMUNOPHENOTYPING RABBIT CELL-MEDIATED IMMUNITY.
Dates and value
- Award date
- Signed on Jun 30, 2020
- Potential end of performance
- Dec 30, 2022
- Current value
- $540,608Base and exercised options
- Potential value (if all options are exercised)
- $540,608
Obligations by fiscal year of action
- FY2020: $540,608
Total across 1 fiscal year: $540,608
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 23, 2022. View on USAspending · Recipient on SAM.gov
Recipient
LocationSAN DIEGO, CA
UEITYHDLNB65NJ1
CAGE code6G3U6
Business sizeSmall businessSize at award, per the contracting officer
Organization typePartnership
Parent companyABTERRA BIOSCIENCES, INC.
Business types and certifications
For-profit organizationLimited liability companyPartnership or LLP
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- San Diego, California 92121-1126
- Congressional district (place of performance)
- CA-50As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competition after exclusion of sourcesD
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- Small business set aside - totalSBA
- Contract pricing
- Firm fixed priceJ
- Offers received
- 5
Solicitation and notices
- Solicitation ID
- PHS2020-01(as reported)
- Solicitation date
- Jul 10, 2019
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Comprehensive reagents for immunophenotyping rabbit cell-mediated immunity
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jun 30, 2020Base obligation at award: $540,608
- Latest action
- May 23, 2022 — Other administrative actionModification P00007; administrative: no change in scope or value
- Actions by type
- Base award1
- Other administrative action8
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Research program (SBIR/STTR)
- Small business innovation research program phase i actionSR1
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 9
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2020/2020-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression